Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (10)
  • 2025 (73)
  • 2024 (73)
  • 2023 (93)
  • 2022 (102)
  • 2021 (64)
  • 2020 (11)
  • 2019 (3)
  • 2018 (1)
  • 2017 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • Money Laundering (210)
  • Gangs (200)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (253)
  • Outreach/Drug Prevention (187)

Drug Name

  • Fentanyl (86)
  • Opioids (58)
  • Oxycodone (39)
  • Synthetic Opioids (25)
  • Methamphetamine (20)
  • Hydromorphone (16)
  • Benzodiazepines (11)
  • Cocaine (7)
  • Morphine (7)
  • Amphetamines (6)
  • Marijuana (Cannabis) (5)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (56)
  • New England (38)
  • Omaha (36)
  • Seattle (36)
  • Sede (33)
  • New York (26)
  • Chicago (20)
  • El Paso (19)
  • Houston (18)
  • Miami (17)
  • St. Louis (17)
  • New Jersey (16)
  • New Orleans (16)
  • Atlanta (15)
  • Rocky Mountain (14)
  • Phoenix (11)
  • San Francisco (9)
  • San Diego (8)
  • Dallas (7)
  • Los Angeles (7)
  • Detroit (6)
  • Louisville (3)
  • Philadelphia (3)
Clear All Results
431 Results - Showing 411 to 420
PRESS RELEASE

DEA Rolls Out Operation Engage

DETROIT – Today the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The initiative...
PRESS RELEASE

DEA Rolls Out Operation Engage

ALBUQUERQUE, N.M. – Today the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The...
PRESS RELEASE

DEA Rolls Out Operation Engage in Anchorage

Anchorage, Alaska – Today the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The...
PRESS RELEASE

DEA and SAMHSA announce winners of Red Ribbon Week campus video Public Service Announcement contest

WASHINGTON – The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration named North Dakota State College of Science, and the University of Miami winners of the 5th Annual Red Ribbon Week Campus Video PSA Contest. The contest, co-sponsored by DEA and SAMHSA, was part of the...
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

DEA podcast about drug misuse among college students wins award

WASHINGTON – The U.S. Drug Enforcement Administration’s podcast series, Prevention Profiles: Take Five , has received a Second Place Blue Pencil & Gold Screen Award from the National Association of Government Communicators. Prevention Profiles: Take Five highlights issues related to preventing drug misuse among college students. Each podcast episode is...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

Paginación

  • Primera página «
  • Anterior
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Current page 42
  • Page 43
  • Page 44
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster